PAIGX
Price
$28.29
Change
+$0.31 (+1.11%)
Updated
Aug 21 closing price
Net Assets
17.34B
VIHAX
Price
$50.90
Change
+$0.55 (+1.09%)
Updated
Aug 21 closing price
Net Assets
21.87B
Interact to see
Advertisement

PAIGX vs VIHAX

PAIGX vs VIHAX Comparison Chart in %
View a ticker or compare two or three
VS
PAIGX vs. VIHAX commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PAIGX is a StrongBuy and VIHAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIHAX has more cash in the bank: 21.9B vs. PAIGX (17.3B). VIHAX pays higher dividends than PAIGX: VIHAX (3.45) vs PAIGX (2.11). PAIGX was incepted earlier than VIHAX: PAIGX (24 years) vs VIHAX (10 years). PAIGX (1.08) is less costly to investors than VIHAX (0.16). PAIGX is a more actively managed with annual turnover of: 15.00 vs. VIHAX (9.00). PAIGX has a lower initial minimum investment than VIHAX: PAIGX (2500) vs VIHAX (3000). PAIGX annual gain was more profitable for investors over the last year : 27.43 vs. VIHAX (25.96). PAIGX return over 5 years is better than : 99.82 vs. VIHAX (66.41).
PAIGXVIHAXPAIGX / VIHAX
Total Expense Ratio1.080.16675%
Annual Report Gross Expense Ratio1.080.16675%
Fund Existence24 years10 years-
Gain YTD17.28917.60198%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets17.3B21.9B79%
Annual Yield % from dividends2.113.4561%
Returns for 1 year27.4325.96106%
Returns for 3 years95.0275.63126%
Returns for 5 years99.8266.41150%
Returns for 10 years150.08108.07139%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RMOCX19.250.23
+1.21%
Victory RS Mid Cap Growth C
CIVHX22.290.17
+0.77%
American Funds Intl Vntg 529-F-3
GSYPX45.930.22
+0.48%
Goldman Sachs Small Cap Value P
PASTX68.290.18
+0.26%
T. Rowe Price Science & Tech Adv
JMNCX12.25-0.01
-0.08%
JPMorgan Research Market Neutral C